1312 — Kontafarma China Holdings Share News
0.000.00%
Last trade - 00:00- HK$150.89m
- HK$181.12m
- HK$914.71m
Brief: Kontafarma China Appoints Li Qingshan As Executive Director And President
Brief: Kontafarma China Sees HY Consol Net Loss Of HK$67.2 Million-HK$100.7 Million
Brief: Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
Brief: Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr
Brief: Kontafarma China Posts Loss For Year Attributable HKD 427.8 Million
Brief: Kontafarma China Expects FY2025 Consolidated Net Loss Of HK$414.1 Million-HK$506.2 Million
Brief: Kontafarma China Says Qiao Linna Resigns As Executive Director, Vice President
Brief: Kontafarma China Logs H1 Net Income HKD -321.4 Mln
Brief: Kontafarma China Says Unit Enters Contract For R+D Complex At RMB33.7 Million
Brief: Kontafarma China Expects Net Loss Of Hk$282.8M-Hk$345.6M For HY
Brief: Kontafarma China Sees Consol Net Loss Of Hk$79.2 Million To HK$118.8 Million For FY
Brief: Kontafarma China Updates On Winding Up Petition Against Unit
Brief: Kontafarma China Says Si Tou Man Wai Tendered Resignation As Vice President
Brief: Kontafarma China Sees HY Consolidated Net Loss Hk$4 Million To Hk$8 Million
Brief: Kontafarma China Announces Provision Of Loan To True Concept
Brief: Kontafarma China Says Winding Up Petition
Brief: Kontafarma China Says Huang Yu Re-Designated To Non-Executive Director
Brief: Kontafarma China Sees Consolidated Net Loss Of HK$49 Mln To HK$73.6 Mln For FY 2023
Brief: Kontafarma China Says Huakong Seg Received Warning Letter